How Are Proteomic Markers Involved in Treatment Decisions?
The presence or absence of specific proteomic markers can influence treatment choices. For example, patients with breast cancer who overexpress the HER2 protein may benefit from targeted therapies such as trastuzumab. Identifying these markers helps tailor treatments to individual patients, enhancing the efficacy and reducing unnecessary side effects.
